- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 22.09. | Magle Chemoswed Holding AB: Magle Group Completes Restructuring Of Its Outstanding Debt And Capital Structure | 240 | GlobeNewswire (Europe) | Magle Chemoswed Holding AB (publ) ("Magle Group" or the "Company") announces that it has completed the restructuring of its outstanding debt and capital structure (the "Restructuring") as previously... ► Artikel lesen | |
| 10.09. | Magle Chemoswed Holding AB: Magle Chemoswed Holding AB (publ) appoints Aaron Wong as Chief Executive Officer | 248 | GlobeNewswire (Europe) | The Board of Directors of Magle Chemoswed Holding AB (publ) ("Magle Group" or the "Company") has today appointed Aaron Wong as Chief Executive Officer of the Company on a permanent basis, effective... ► Artikel lesen | |
| 02.09. | Magle Chemoswed Holding AB: Magle Chemoswed Holding AB (publ) initiates implementation of restructuring following successful written procedure | 200 | GlobeNewswire (Europe) | Magle Chemoswed Holding AB (publ), org. no. 556913-4710 (the "Company"), today on 2 September 2026 announces that it will initiate the implementation of the contemplated amendments and waivers as set... ► Artikel lesen | |
| 26.08. | Magle Chemoswed Holding AB: Bulletin from the extraordinary general meeting in Magle Chemoswed Holding AB (publ) | 189 | GlobeNewswire (Europe) | Magle Chemoswed Holding AB (publ), org. no. 556913-4710 (the "Company"), held today, on 26 August 2026, an extraordinary general meeting (the "EGM") at the Company's premises at Agneslundsvägen 20B... ► Artikel lesen | |
| 17.08. | Decision by the Disciplinary Committee regarding Magle Chemoswed Holding AB | 305 | GlobeNewswire | Stockholm, August 17, 2026 - The Disciplinary Committee of Nasdaq Stockholm (the "Exchange") has found that Magle Chemoswed Holding AB (the "Company") has breached the rules of Nasdaq First North... ► Artikel lesen | |
| 12.08. | Magle Chemoswed Holding AB: Magle Chemoswed Holding Reports Financial Results For Second Quarter 2026 | 155 | GlobeNewswire (Europe) | Early signs of stabilisation in a year of transition
Q2 2026 KEY INDICATORS (Apr-Jun)Total revenue amounted to 74.6 MSEK (55.2)EBITDA equalled 1.5 MSEK (-20.6)Operating profit (EBIT) was -13.1 MSEK... ► Artikel lesen | |
| 27.07. | The observation status for Magle Chemoswed Holding AB is updated | 289 | GlobeNewswire | On June 9, 2026, the shares in Magle Chemoswed Holding AB (the "Company") were given observation status with reference to uncertainty in respect of the issuer's financial position.
Today, July... ► Artikel lesen | |
| 27.07. | Magle Chemoswed Holding AB: The board of Magle Chemoswed Holding AB (publ) proposes that the EGM resolves on voluntary delisting of the company's shares from Nasdaq First North Growth Market | 302 | GlobeNewswire (Europe) | The board of directors of Magle Chemoswed Holding AB (publ), reg. no. 556913-4710 (the "Company"), has today resolved to propose that an extraordinary general meeting resolves on the delisting of the... ► Artikel lesen | |
| MAGLE CHEMOSWED Aktie jetzt für 0€ handeln | |||||
| 10.07. | Magle Chemoswed Holding AB: Magle Group Has Resolved On A Restructuring Of Its Outstanding Debt And Capital Structure, Including Debt-for-equity Swap, Issuance Of Super Senior Bonds And Directed Share Issues | 582 | GlobeNewswire (Europe) | As previously announced, Magle Chemoswed Holding AB (publ) ("Magle Group" or the "Company") has for some time been in constructive negotiations with bondholders representing approximately 79 per cent... ► Artikel lesen | |
| 30.06. | Magle Chemoswed Holding AB: Bulletin from the Annual General Meeting in Magle Chemoswed Holding AB (publ) | 249 | GlobeNewswire (Europe) | Magle Chemoswed Holding AB (publ), reg. no. 556913-4710 (the "Company"), today, on 30 June 2026, held its Annual General Meeting at the Company's premises at Agneslundsvägen 20B in Malmö. The following... ► Artikel lesen | |
| 25.06. | Magle Chemoswed Holding AB: Magle Group announces deferral of interest payment in respect of its bonds, and update to timing of intended financial restructuring | 293 | GlobeNewswire (Europe) | As communicated by Magle Chemoswed Holding AB (publ) ("Magle Group" or the "Company") on 11 June 2026, the Company received a proposal from an ad hoc group of bondholders (the "Ad Hoc Group") in respect... ► Artikel lesen | |
| 09.06. | Magle Chemoswed Holding AB receives observation status | 241 | GlobeNewswire | On June 7, 2026, Magle Chemoswed Holding AB (the "Company") disclosed a press release with an update regarding the Company's financing arrangements.
According to item 6.1.3 (b) (iv) of the Nasdaq... ► Artikel lesen | |
| 07.06. | Magle Chemoswed Holding AB: Magle Chemoswed Holding AB - Update on Financing Arrangements and Ongoing Stakeholder Discussions | 336 | GlobeNewswire (Europe) | Magle Chemoswed Holding AB (publ) ("Magle" or the "Company") provides an update regarding its financing arrangements and ongoing discussions with key stakeholders.
Danske Bank Facility Maturing on 30... ► Artikel lesen | |
| 31.05. | Magle Chemoswed Holding AB: Magle Chemoswed Holding Reports Financial Results For First Quarter 2026 | 304 | GlobeNewswire (Europe) | A difficult quarter in a year of necessary change
Q1 2026 KEY INDICATORSTotal revenue amounted to 71.7 MSEK (85.1)EBITDA equalled -6.6 MSEK (12.8)Operating profit (EBIT) was -17.8 MSEK (2.1)Profit after... ► Artikel lesen | |
| 26.05. | Magle Chemoswed Holding AB: Bulletin from the extraordinary general meeting in Magle Chemoswed Holding AB (publ) | 342 | GlobeNewswire (Europe) | Magle Chemoswed Holding AB (publ), reg. no. 556913-4710 (the "Company"), today, on 26 May 2026, held an Extraordinary General Meeting (the "EGM") at the Company's premises at Agneslundsvägen 20B in... ► Artikel lesen | |
| 12.05. | New last trading day for paid subscription shares (BTA) of Magle Chemoswed Holding AB | 314 | GlobeNewswire | At the request of Magle Chemoswed Holding AB, the last trading day in Magle Chemoswed Holding AB's paid subscription shares will be changed from 2026-05-20 to 2026-05-13.
Instrument:
Paid subscription... ► Artikel lesen | |
| 30.04. | Magle Chemoswed Holding AB: Magle Group Announces Outcome of Rights Issue | 327 | GlobeNewswire (Europe) | THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH... ► Artikel lesen | |
| 14.04. | Magle Chemoswed Holding AB: Magle Group Publishes Information Document in Connection with Upcoming Rights Issue | 368 | GlobeNewswire (Europe) | THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH... ► Artikel lesen | |
| 13.04. | XFRA CAPITAL ADJUSTMENT INFORMATION - 13.04.2026 | 260 | Xetra Newsboard | Das Instrument LUR SE0015192075 LUXBRIGHT AB EQUITY wird ex Kapitalmassnahme gehandelt am 13.04.2026 The instrument LUR SE0015192075 LUXBRIGHT AB EQUITY is traded ex capital adjustment on 13.04.2026Das... ► Artikel lesen | |
| 10.04. | Magle Chemoswed Holding AB: Bulletin from the extraordinary general meeting in Magle Chemoswed Holding AB (publ) | 264 | GlobeNewswire (Europe) | Magle Chemoswed Holding AB (publ), reg. no. 556913-4710 (the "Company"), today, on 10 April 2026, held an Extraordinary General Meeting (the "EGM") at the Company's premises at Agneslundsvägen 20B in... ► Artikel lesen |
1 2 Weiter >>
29 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES | 40,180 | -0,04 % | Teva/Sanofi: Duvakitug Maintains Meaningful Efficacy Improvements In Long-term Extension Study | PETAH TIKVA (dpa-AFX) - Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries (TEVA), and Sanofi announced new positive data from the RELIEVE UCCD phase 2b long-term extension... ► Artikel lesen | |
| MERCK KGAA | 144,10 | -1,54 % | Eli Lillys Umsatzsprung, Mercks 11,3-Milliarden-Dollar-Deal: Wie Zelltherapien in die Wachstumsstory der Pharmabranche passen | ||
| BAYER | 43,940 | -0,61 % | Bayer: Wird Nubeqa zum größten Medikament der Firmengeschichte? | Auf dem Krebskongress ESMO stehen Zwischendaten zu Bayers Prostatakrebsmittel Nubeqa an. Die BofA rechnet mit einem klaren Erfolg und traut dem Medikament den Rekord in der Konzerngeschichte zu. Bayer... ► Artikel lesen | |
| ETON PHARMACEUTICALS | 50,13 | +0,22 % | Biotech Stocks At 52-Week Highs - Eton Pharmaceuticals +44%, DexCom, Oruka Therapeutics, Concentra Group Holdings Parent, AtaiBeckley | INDIANAPOLIS (dpa-AFX) - The following biotech stocks reached 52-week highs on August 14, 2026, following positive quarterly reports or an announced upcoming acquisition. Eton Pharmaceuticals... ► Artikel lesen | |
| IAMBIC THERAPEUTICS | 14,520 | -1,02 % | Biotech an der Börse: Iambic-IPO bringt 150 Millionen USD für Krebsmedikamente | Das US-Biotechunternehmen Iambic setzt bei neuen Krebsmedikamenten auf künstliche Intelligenz. Mit dem frischen Börsenkapital will es klinische Studien voranbringen und seine Forschungstechnik ausbauen.... ► Artikel lesen | |
| NOVO NORDISK | 35,375 | +0,65 % | Novo Nordisk muss zittern: Eli Lilly vor Milliardenchance: Neue Abnehmpille nimmt wichtige EU-Hürde! | Eli Lillys Abnehmpille Foundayo nimmt eine wichtige EU-Hürde. Die mögliche Zulassung verschärft den Milliardenwettbewerb mit Novo Nordisk Enthaltene Werte: US5324571083,DK0062498333Den vollständigen... ► Artikel lesen | |
| AQUESTIVE THERAPEUTICS | 4,130 | 0,00 % | H.C. Wainwright bekräftigt Kaufempfehlung für Aquestive nach FDA-Fortschritten | ||
| GENERATE BIOMEDICINES | 12,800 | +0,08 % | Generate Biomedicines, Inc.: Roswell Park, Generate Biomedicines Launch Exclusive Clinical Trial of 'Armored' CAR T Therapy for Ovarian Cancer | Engineered with AI to optimize T-cell function in solid tumors, GB-5267 is the first next-generation cell therapy for ovarian cancer to enter clinical trials First patient treated in new clinical... ► Artikel lesen | |
| LB PHARMACEUTICALS | 39,460 | +0,10 % | Stifel reiterates Buy rating on LB Pharmaceuticals stock at $53 | ||
| KARDIGAN | 12,740 | 0,00 % | Baird stuft Kardigan mit "Outperform" ein - Kursziel 43 US-Dollar | ||
| OMNIAB | 4,770 | -0,21 % | OmniAb auf der LD Micro Konferenz: Lizenzgebühren, Skalierung und Geduld im Fokus | ||
| BRIGHT MINDS BIOSCIENCES | 52,50 | -0,36 % | Levoit and Cosori: 5 Back to School Wellness Heroes for the Bright Minds of Tomorrow | DUBAI, UAE, Aug. 21, 2026 /PRNewswire/ -- Levoit and Cosori unveil five smart home solutions to tackle back to school stresses: polluted indoor air, relentless AC dryness, post snack floor... ► Artikel lesen | |
| APNIMED | 18,540 | +0,05 % | Apnimed, Inc.: Apnimed Reports Second Quarter 2026 Financial Results and Provides Corporate Update | U.S. Food and Drug Administration ("FDA") Accepted the NDA for AD109, with a proposed proprietary name Oxnimbi- and assigned a PDUFA target action date of February 28,- 2027 If approved, Oxnimbi... ► Artikel lesen | |
| ROCHE | 423,00 | -0,57 % | RBC stuft ROCHE HOLDINGS AG auf 'Outperform' | NEW YORK (dpa-AFX Analyser) - Die kanadische Bank RBC hat die Einstufung für Roche mit einem Kursziel von 400 Franken auf "Outperform" belassen. Seine Umsatzprognose für das dritte Jahresviertel liege... ► Artikel lesen | |
| SANOFI | 74,15 | -0,66 % | RBC stuft SANOFI auf 'Neutral' | NEW YORK (dpa-AFX Analyser) - Die kanadische Bank RBC hat das Kursziel für Sanofi vor Zahlen für das dritte Quartal von 80 auf 75 Euro gesenkt und die Einstufung auf "Sector Perform" belassen. Die Stärke... ► Artikel lesen |
Das Unternehmen MAGLE CHEMOSWED HOLDING AB kann der Branche Pharma zugeordnet werden. Der aktuelle Kurs liegt bei 0,031 Euro und damit 0,00 % im Plus. Beim derzeitigen Kurs ergibt sich, basierend auf einer gesamten Ausschüttung von 0,00 Euro in den vergangenen 12 Monaten, eine Dividendendrendite von 0,00 %.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu MAGLE CHEMOSWED HOLDING AB finden Sie auf Wallstreet Online.